Aktis Oncology Inc Net Income per Employee (AKTS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Aktis Oncology Inc   (NASDAQ: AKTS)
    Sector  Technology    Industry Consumer Electronics
   Industry Consumer Electronics
   Sector  Technology
 

Aktis Oncology Inc Net Income per Employee

AKTS's Quarterly Results, Trends, Rankings, Statistics
Aktis Oncology Inc recorded a cumulative net loss of $-76 million during 12 month ending in the second quarter 2026.
The Technology sector has seen employees of 35 other companies achieving higher income per employee. While Aktis Oncology Inc 's total ranking has deteriorated compared to the previous quarter from 2537 to 3279.


What is Income per Employee Ratio?






AKTS Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Sep 30 2024)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -375,766 -287,587 -342,786 -368,821 -372,433
AKTS's Total Ranking # 3279 # 2537 # # #
Seq. Net Income Change - - - - -


AKTS Net Income per Employee Company Ranking
Within: No.
Consumer Electronics Industry # 36
Technology Sector # 501
Overall Market # 3279

Net Income per Employee Statistics
High Average Low
$ -4,241 $ -193,239 $ -440,637
(Jun 30 2015)   (Jun 30 2024)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Technology Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026


Date modified: 2026-09-03T11:29:19+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.